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A B S T R A C T
Eight novel silicate, phosphate and borate glass compositions (coded as NCLx, where x = 1 to 8), containing
different oxides (i.e. MgO, MnO2, Al2O3, CaF2, Fe2O3, ZnO, CuO, Cr2O3) were designed and evaluated alongside
apatite-wollastonite (used as comparison material), as potential biomaterials for bone tissue repair and
regeneration. Glass frits of all the formulations were processed to have particle sizes under 53 μm, with their
morphology and dimensions subsequently investigated by scanning electron microscopy (SEM). In order to
establish the nature of the raw glass powders, X-ray diffraction (XRD) analysis was also performed. The sintering
ability of the novel materials was determined by using hot stage microscopy (HSM). Ionic release potential was
assessed by inductively coupled plasma optical emission spectroscopy (ICP-OES). Finally, the cytotoxic effect of
the novel glass powders was evaluated for different glass concentrations via a colorimetric assay, on which basis
three formulations are considered promising biomaterials.
G R A P H I C A L A B S T R A C T
1. Introduction
The first reported use of a glass intended for bone tissue repair dates
back to 1969, when Professor L. Hench proposed a composition in the
Na2O-CaO-SiO2-P2O5 system, designated as bioglass 45S5 [1,2], com-
mercially known as Bioglass®.
Although Bioglass® proved to be an excellent material, considered
for long time the gold standard bone substitute, it suffers from several
drawbacks. Specifically, the main difficulties are related to the material
processing in form of 3D porous scaffolds, due to the limited ability of
this glass in sintering [3]. Additionally, other weaknesses include: its
slow degradation kinetic with the consequent difficulties to match the
formation rate of new tissue, and the abrupt pH variations of the
biological microenvironment, due to the increase in the concentration
of ions such as Na+ and Ca2+, especially in the short term when the
release is faster [4–6].
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Worldwide many researchers have used the SiO2-Na2O-CaO-P2O5
system as a template for developing new silica-based compositions [7].
Subsequently, many formulations in the phosphate and borate-based
system have been also designed to overcome the Bioglass® and silicate-
based glass limitations [8–11], and thus to meet the set of requirements
that are both crucial and necessary for optimised tissue-engineered
substitutes [12].
The possibility to tailor glass properties by doping the main
composition with network modifiers and/or intermediate oxides
[13–20] offers significant potential for this class of biomaterials. In
addition to promoting bone bonding, the release of soluble ions (i.e. Si,
Ca, P and Na) from these glasses have been demonstrated to promote
cell proliferation, differentiation and activate gene expression [20–24].
Furthermore, it has been also revealed that even slight changes in the
glass main formulation can substantially affect the material behaviour,
particularly the physico-chemical and mechanical properties, dissolu-
tion rate, bioactivity and bioresorbability [5,16,18,25–27].
However, there are still several criticisms related to the clinical use
of this class of biomaterials in bone repair [12]. Firstly, whether or not
glass dissolution products have a positive effect on adult stem cells is
still an open debate [28]. Secondly, they have often proved inadequate
when used in load-bearing bone defects, due to their low tensile
strength and fracture toughness [29]. Ultimately, there are no large-
scale porous bioactive glasses on the market, thus their commercial
success as bone scaffolds is limited [6,12].
The aim of this work was the development and characterisation of
eight novel silicate, phosphate and borate glass formulations (coded as
NCLx, where x = 1 to 8), containing different oxides and in diverse
molar percentages as promising biomaterials for the repair and
regeneration of bone tissue.
2. Materials and methods
2.1. Development of novel glass formulations
Based on the current state of the art, the eight bioceramic formula-
tions were developed using: silicon dioxide, phosphorous pentoxide and
boron trioxide as network formers due to their promising bioactive
potential [1,30,31], distinctive resorbable properties [32,33], and
customable degradation rate [5,34], along with a range of different
doping agents (i.e. MgO, MnO2, Al2O3, CaF2, Fe2O3, ZnO, CuO, Cr2O3),
which were used to tailor the properties of the main composition
[35–41]. The rationale and innovative characteristics of the novel
materials are reported in Table 1. Additionally, considering the
excellent biocompatibility either in vitro and in vivo of apatite wollas-
tonite (AW) [42–44], and the fact that it has been adopted for a broad
range of medical applications, either in the form of powder, porous
structures or bulk material [45,46], AW glass-ceramic was used as
comparison material in this study.
2.2. Glass production and processing
The novel glasses were produced and supplied by Glass Technology
Service (GTS) Ltd. (Sheffield, UK) along with AW. Briefly, the indivi-
dual components (see Table 2) of each formulation were weighed out
and then mixed together to obtain a uniform blend, which was
subsequently melted in platinum crucibles at temperatures up to
1500 °C. The individual melts of glass were cast as solid blocks and
then thermally shocked in de-ionised water to produce the precursor
materials, known as frits.
Glass frits of all the compositions were ground in a one-bowl
zirconia ball milling machine (Planetary Mono Mill Pulverisette 6,
Fritsch GmbH, Germany) using a rotational speed of 400 rpm for
30 min, and then sieved using a mechanical sieve shaker (Impact Test
Equipment Ltd., UK) to have a final particle size about 20 μm and below
53 μm.
Powders were prepared for pressing through mixing with an
isopropanol solution (Sigma Aldrich, UK) in the proportion 1:3 (w/
w). Powders were then pressed using an automatic hydraulic press
(Specac-Atlas™ 8T, Specac Ltd., UK) to make 10 mm diameter and
2.5 mm high pellets. The pressed pellets were then sintered in a furnace
(Carbolite 1200 CWF, Carbolite GmbH, Germany), with the sintering
times and temperatures defined by the results of the hot stage
microscopy analysis, reported in Section 2.3.2.
2.3. Physico-chemical characterisation
2.3.1. Microstructural characterisation
Powder glasses and dense pellets were sputtered with a thin layer of
gold (approximately 10 nm, sputter time 40 s at 40 mA), and afterward
analysed using a Philips XL30 Field-Emission Environmental Scanning
Electron Microscope (ESEM FEG), which is fitted with a Rontec
Quantax system for the Energy-Dispersive Spectroscopy (EDS) analysis.
All the images were taken at an operation voltage of 20 kV, and
working distance between 5 and 10 mm.
2.3.2. Hot stage microscopy (HSM)
The sintering ability of the novel glass powders was determined
using hot stage microscopy (Misura®, Expert System Solutions, Italy).
Tests were performed in air using a heating rate of 10 °C/min up to
1200 °C. Glass powders were manually pressed into a small cylindrical
die (2 × 3 mm) and placed on a 10 × 15 × 1 mm alumina support.
During the process the specimens were observed by a video camera and
images of the changing sample profile were acquired up to 1450 °C.
Afterwards, the sample shrinkage at different temperatures was calcu-
lated from the variation of the sample area, using the following
formula:
A
A
shrinkage (%) = × 100T
0
where A0 (mm2) was the initial area of the specimen at room
temperature and AT (mm2) was the area of the specimen at the
temperature T.
2.3.3. XRD Analysis
To investigate the nature of the novel materials. XRD analysis was
Table 1
Rationale of the novel glass compositions.
CODE MAIN NETWORK FORMER AIM
NCL1 SiO2 To develop a material with osteogenic properties, mainly determined by the presence of a high amount of silica.
NCL2 SiO2 To develop a load-bearing material with osteogenic properties and tailored degradation rate.
NCL3 B2O3 To develop a material with improved degradation rate and appropriate level of bioactivity as well as mechanical properties
NCL4 B2O3 To develop a material with tailored degradation rate and osteogenic effects.
NCL5 P2O5 To develop a resorbable glass with controlled degradation rate.
NCL6 P2O5 To develop a resorbable glass with controlled degradation rate, and improved mechanical strength
NCL7 SiO2 To develop a material with antibacterial properties, mainly determined by the presence of silver oxide, and a good level of bioactivity.
NCL8 SiO2 To develop a material with osteogenic properties and tailored degradation rate for non-load bearing applications.
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performed using a PANalytical X'Pert Pro MPD, powered by a Philips
PW3040/60 X-ray generator, and fitted with an X'Celerator detector.
Diffraction data was acquired by exposing powder samples to Cu-Kα X-
ray radiation, at 40 kV and 40 mA. The data were collected over a 2θ
range between 5 and 80°, with a step size equal to 0.0334°, a counting
time per step of 200 s using the scanning X'Celerator detector. Phase
identification was carried out using the PANalytical X'Pert HighScore
Plus© software.
2.3.4. Ion leaching evaluation
Un-sintered glass powders with a concentration of 10 mg/ml were
immersed in deionised water (Veolia Water Technologies, UK) and
incubated under an atmosphere of 5% CO2 and 95% air at 37 °C. After
each storage period (1, 3, 7, 14 and 28 days), the specimens were
removed via filtration, and filtrates retained to analyse the ion release
potential of each compositions. An inductively coupled plasma optical
emission spectroscopy (ICP-OES) (Specto-Ciros-Vision, Sheffield
University, UK), which allows simultaneous multi-element analysis
following the calibration of the instrument by standards of known
concentrations of the elements of interest, was employed.
2.4. Biological characterisation
The in vitro cytotoxicity of the novel glass formulations was
evaluated according to ISO 10993–5 [47] using rat calvaria osteoblast
cells in indirect contact with glass powders up to 7 days. Each powder
sample was firstly sterilised using 100% ethanol solution, and after
added to Dulbecco's modified Eagle medium (DMEM, Gibco® UK) at
three different concentrations (0.1, 1 and 10 mg/ml) and incubated for
24 h at 37 °C. After incubation, the glass-conditioned medium was
filtered through a 0.22 μm microbiological filter, and used for in vitro
tests.
Cells at early passages were provided by Institute of Cellular
Medicine (Medical School, Newcastle University, UK), and then were
cultured in T75 flasks at 37 °C in a humidified incubator with 5% CO2,
using DMEM supplemented with 10% fetal bovine serum (FBS), 1%
penicillin-streptomycin and 1% glutamine (Gibco®, UK). Cells were
seeded at a density of 1x104cells/well in 96-well plates and incubated
at 37 °C. After 24 h culture period the culture media was discarded and
replaced with the filtered solution for indirect cytotoxicity testing. Rat
OBs cultured in the absence of glass powders were used as negative
control.
The culture plates were then incubated for 1 and 7 days. The
cytotoxic effect was measured exposing each well to 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT,
Sigma–Aldrich, UK) solubilisation at a concentration of 0.5 mg/ml.
100 μl of MTT solution was added to each well and incubated at 37 °C
for another 4 h. MTT was taken up only by active cells and reduced in
their mitochondria to insoluble purple formazan granules. The medium
was then removed and 100 μl of dimethyl sulfoxide (DMSO) was added
to dissolve the precipitated formazan. The absorbance of the solution
was evaluated spectrophotometrically at a wavelength of 570 nm, and
acquired using a Sunrise microplate reader (Tecan Group Ltd.,
Switzerland).
The absorbance values from three replicates were averaged and
statistically analysed using two–way analysis of variance (ANOVA)
followed by Bonferroni post hoc analysis. P-values< 0.05 were con-
sidered statistically significant.
3. Results
3.1. Glass production and powder processing
During synthesis, composition NCL5 could not form a glass at any
temperature up to 1500 °C, which was the highest temperature the
available furnaces could reach. Glass frits from the seven compositions
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which did form a glass, were ground using a zirconia ball mill, and
sieved to obtain fine powder in the range 0-53 μm.
3.2. Glass powder microstructural analysis
Fig. 1(a–h) shows the morphology of as-synthesised glass powders.
Non-spherical and irregular shape particles with sharp edges can be
observed for all the compositions. Furthermore, it can be seen that for
all the glasses most of the particles were very fine (ranging from 20 μm
to 53 μm), with the presence also of grains smaller than 10 μm, which
tended to compact producing aggregates.
3.3. HSM
The experiments started at room temperature (TR) with heating rate
of 10 °C/min up to 1450 °C. All the specimens maintained their initial
rectangular shape before the first shrinkage temperature (TFS), which
varied between 550 °C and 1225 °C (see Fig. 2(a–h)). For temperatures
higher than the corresponding TFS, the samples started to shrink until
the temperature of maximum shrinkage (TMS). The variation of sample
Fig. 1. SEM analysis (magnification 1500×) showing the glass powders morphology: a) NLC1, b) NCL2, c) NCL3, d) NCL4, e) NCL6, f) NCL7, g) NCL8, and h) AW.
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dimensions during the sintering process are reported in Fig. 2(a–h).
Fig. 2(a–b, f–g) reveal also how the silicate-based specimens (NCL1,
NCL2, NCL7 and NCL8), before reaching the melting status at complete
melting temperature (TCM), started to expand up to their temperature of
maximum volume (TMV). Furthermore, these silicate-based glasses
showed a similar thermal profile, whereas the phosphate-based
(NCL6) had a thermal curve (Fig. 2(e)) more comparable to the
borate-based glasses (NCL3 and NCL4) (Fig. 2(c–d)).
Fig. 2. Shrinkage profile derived from hot stage microscopy as function of temperature for: a) NCL1, b) NCL2, c) NCL3, d) NCL4, e) NCL6, f) NCL7, g) NCL8 and h) AW.
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3.4. XRD
The XRD patterns of the raw materials are reported in Fig. 3. For
NCL1, NCL2, NCL3, NCL4, and NCL8 the presence of a broad peak,
common for glass samples, indicated the completely amorphous nature
of these compositions. The amorphous peak was detected at 2θ values
between 25° and 30°, and confirmed that NCL1, NCL2, NCL3, NCL4 and
NCL8 formulations were free from any detectable crystalline phase.
Different patterns were detected for NCL6 formulation, which showed a
glass-ceramic nature with a crystalline phase identified as calcium
sodium phosphate (ICDD ref. code 01-074-1950). Moreover, for the
NCL7 composition a silver crystalline phase (ICDD ref. code 04-003-
1425) was detected. Regarding the AW composition, the presence of
hydroxylapatite phase (ICDD ref. code 01-080-6260) and a less intense
β-wollastonite phase (ICDD ref. code 04-010-0710) were observed,
proving the glass-ceramic structure of this material.
3.5. Ion leaching evaluation
The ionic release of the common elements (Si, P, B, Ca and Mg) of
each glass composition is reported in Fig. 4. It is interesting to observe
that, except for NCL2 composition, the amount of silicon released in
solution after 28 days was proportional to the molar content present in
the main formulation. As network former, boron was released very
quickly in comparison to silicon and phosphorous, and it displayed a
progressive increase over the time period for both NCL3 and NCL4
compositions. Moreover, it was found that the amount of phosphorous,
as main network former, in the NCL6 composition was released more
slowly than boron from NCL3 and NCL4 formulations.
3.6. Bioceramic pellets sintering and characterisation
Sintering was performed with a heating rate of 10 °C/min up to a
maximum temperature in the range 550–850 °C, which was held for
1 h; after this the samples were left to cool down at room temperature.
Sintering temperatures were selected on the basis of the HSM results.
SEM investigations were conducted to evaluate the effect of different
maximum temperatures on sample morphology. Fig. 5 reports the pellet
surface of each composition for two heat treatments per material.
Micrographs (a) of Fig. 5 show a poor sintering level for all the
formulations, where glass particles started to aggregate, but were not
properly sintered. The microstructures reported in micrographs (b) of
Fig. 5 demonstrate how an increase in the heating temperatures led to
an appropriate densification status, as a result of increased liquid phase.
Particularly for NCL1, NCL3, NCL6, NCL7, NCL8 and AW compositions
the formation of sintering necks (red arrows in the figure) became
evident.
In light of the SEM microstructural observations, and after a
thorough qualitative analysis, a summary of the heating temperatures
that qualitatively were considered to provide the best densification
degree are shown in Table 3.
3.7. Biocompatibility assay
The MTT results are summarised in Fig. 6. For NCL1 the cells
displayed good metabolic activity after 1 day in culture for all
concentrations tested, however the effect of the glass became detri-
mental after 7 days in culture at a concentration of 10 mg/ml. NCL2
shows not meaningful positive effects on metabolic activity after day 1,
with no significant negative effect compared to control at day 7. The
NCL3, NCL6 and NCL8 formulations all show cytotoxic effects on cell
mitochondrial activity after 7 days in culture, which increases with
increasing quantities of glass powder. NCL4 shows a broadly uniform
response over the time period, with no significant differences in
response across concentrations or time points. The NCL7 composition
showed a positive effect on cell viability and proliferation at both time
points, being this statistically significant for the lowest concentration
after 7 days in culture. For AW glass-ceramic, the findings of this study
confirmed the results of previous work [48], according to which the
material initially has a slightly cytotoxic effect on cell mitochondrial
activity, followed by enhanced cell proliferation.
4. Discussion
For this study eight novel bioceramic formulations were designed in
order to develop biomaterials with beneficial performance towards
bone tissue repair and regeneration, by using i) silicon dioxide, ii)
phosphorous pentoxide and iii) boron trioxide as network formers.
The glasses were synthetized via a melting-quenching route; how-
ever, during the glass production their forming ability was composition
dependant. Even though both NCL5 and NCL6 are phosphate-based
glasses, the NCL5 formulation did not form a liquid at 1500 °C. This
contradicts the commonly held view that phosphate–based glasses can
be prepared at relatively low temperatures [32]. Based on the findings
reported by Abou Neel et al., the incorporation of high density oxides
like SrO2 in the phosphate glass structure might be associated with an
increase of the glass melting temperature; and this is considered the
most likely reason for the poor processability of the NCL5 formulation
[49].
HSM analysis revealed that the silicate-based glasses (NCL1, NCL2,
NCL7 and NCL8) displayed similar thermal profiles, characterised by an
increase in sample dimensions after the maximum shrinkage tempera-
ture and before the melting onset occurred. These results are compar-
able with the findings reported by Baino et al., who found that a less
complex silicate-based glass (CEL2) exhibited a significant volumetric
expansion after the first densification step [14]. Within the scope of the
formulations reported in Table 2, we conclude that the silicate glass
sintering profiles are relatively insensitive to the presence of different
network modifiers in the glass structure.
HSM analysis performed on NCL6 phosphate-based glass showed a
thermal profile with densification that takes place in two steps (elbow-
shape profile). Furthermore, similarly to ICEL2 phosphate glass (45%
P2O5, 3% SiO2, 26% CaO, 7% MgO, 15% Na2O and 4% K2O) [50], NCL6
formulation displayed an HSM thermograph with a volume increase at
temperatures higher than TMS. This observation is consistent with the
findings reported by Arstila et al., according to which the elbow shape
Fig. 3. XRD patterns of as-synthesised glass powders (▲ hydroxylapatite, ■ β-wollas-
tonite, ◆ silver ● calcium sodium phosphate).
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curve could indicate the possible sintering interval of the glass [51,52].
Moreover, the presence of network modifiers such as MnO2, CaF2, CuO,
CoO, Cr2O3, and in particular B2O3 could have affected the thermal
behaviour of this formulation, leading to a shrinkage profile more
comparable to the one developed by the borate-based compositions.
The sintering behaviour of borate-based bioglasses has to date been
explored in less depth than silicate or phosphate based glasses. In this
study, the two borate-based glasses (NCL3 and NCL4) exhibited similar
one-step densification behaviour, with a small sintering interval in
comparison to the silicate and phosphate-based glasses [53].
The selection of sintering temperatures is a key step during the
manufacturing process to consolidate ceramic-based structures [54,55].
Although a further optimisation process (based on thermal treatment
and morphological analysis evaluation) was required, the outcomes
from the HSM were a very useful guide in predicting the optimal
sintering temperatures of bioceramic pellets: the temperatures that led
to optimal consolidated structures, as demonstrated by SEM investiga-
tion, were all in the range of sintering temperatures provided by HSM
[56].
According to the ICP-OES results, and by comparing the release of
the main network formers, boron was released very quickly in
comparison to silicon and phosphorus, therefore proving the highly
reactive nature of borate-based glasses [5]. These findings reflect the
study design (Table 1), which aimed to develop compositions with
tailored degradation rates. It is also notable that the presence of boron
in the glass structure, even as intermediate oxide, enhanced the release
of the other elements (i.e. phosphorous release from NCL3 glass with
respect to NCL1 composition) in the formulation.
For all the novel glasses, apart from the NCL2 composition, silicon
leaching proved to be proportional to its molar content in the parental
Fig. 4. Ionic concentrations of Si, P, B, Ca and Mg released into deionised water from all the formulations, without refreshing the solutions and at different time points (1, 7, 14 and
28 days).
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glass. Additionally, it was found that the release of phosphorus
increased with soaking time only for the NCL6 formulation, in which
it was used as network former, most likely as a result of the higher
levels of phosphorous in NCL6 [32,57].
The results of the in vitro cytotoxicity tests revealed that for high
concentrations of glass powder (10 mg/l), cell mitochondrial activity
was significantly reduced for NCL1, NCL3, NCL6 and NCL8 composi-
tions [58], meaning that the NCL2, NCL4 and NCL7 formulations are
suitable for further study. No single effect provided a direct correlation
between the cytotoxicity and ionic release potential, but a number of
observations can be made:
• For both the NCL1 and NCL3 formulations, it is most likely that the
release of vanadium had a negative effect on cell mitochondrial
activity [59,60].
• The NCL6 composition did not contain many dopants, and because
the release of Co, Cu and Cr after 28 days in immersion was quite
low (data not shown) [61], it is most likely that the high levels of
phosphorus and boron were the cause of the detrimental effect of
this glass.
• No clear reasons for the toxicity of NCL8 were found; hence, the
negative effect is most likely due to the combination of the different
oxides.
• The highly reactive nature of the NCL4 borate-based glass enabled
the release of strontium at a higher rate than NCL1 composition,
which has been demonstrated to increase proliferation as well as
differentiation of osteoblast cells [62,63].
• The positive effect of the NCL7 formulation might derive from the
combined effect of titanium, iron and copper, which enhance
osteoblasts proliferation and activity [64].
5. Conclusion
This paper has presented a systematic process for the evaluation of
novel bioceramic materials, considering basic glass processability, hot
stage microscopy, ICP analysis and a biocompatibility assay. The main
conclusions which can be drawn are:
(i) It is possible for phosphate-based glasses to have high melting
temperatures, as the NCL5 formulation did not form a liquid at
Fig. 5. SEM micrographs of bioceramic pellet surface at (a) low and (b) appropriate sintering level (temperature = °C, magnification = 2500×); red arrows indicate necking formation
phenomena. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Table 3
Sintering intervals of the novel glass formulations (derived from HSM) and optimal
sintering temperatures of dense bioceramic pellets.
Code Composition HSM sintering interval
(°C)
Sintering temperature
(°C)
NCL1 Silicate-based 575–785 625
NCL2 Silicate-based 600–730 700
NCL3 Borate-based 555–625 625
NCL4 Borate-based 550–650 625
NCL6 Phosphate-based 580–775 725
NCL7 Silicate-based 575–785 625
NCL8 Silicate-based 500–730 625
AW Silicate-based 800–1225 850
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1500 °C.
(ii) The sintering range identified by HSM consistently included the
optimum sintering temperature, indicating the usefulness of this
technique in defining sintering routines.
(iii) No direct correlation between ion release and cytotoxicity could be
observed across all of the glasses studied, although silicon release
seems to be mostly dependent on silicon content; and vanadium
does not seem to have enhanced biocompatibility at the concen-
trations studied in this paper.
(iv) Of the eight proposed glasses the NCL2, NCL4 and NCL7 formula-
tions have shown sufficient biocompatability to merit further study
as new biomaterials.
Fig. 6. Effect of a) NCL1, b) NCL2, c) NCL3, d) NCL4, e) NCL6, f) NCL7, g) NCL8 and h) AW glass powders (measured in triplicate) on formazan formation after indirect contact with rat
osteoblast cells, evaluated through MTT assay after 1 day and 7 days in culture. Error bars represent the standard deviation (* = P < 0.05).
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